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Abbreviations 
AE = Adverse effect 
DLPFC = Dorsolateral prefrontal cortex 
tDCS = Transcranial direct current stimulation 
tES = Transcranial electrical stimulation 
PSS = Perceived Stress Scale 
ZIP = Zero-Inflated Poisson 
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- As expected, active tDCS predicted a higher likelihood of an erythema reaction 
- Higher age predicted a higher intensity of the erythema reaction 
- Increasing the number of consecutive sessions did not modify the adverse effects 
  
  3 
We read the paper by Antal et al. (2017) with great interest, and felt that it provided an excellent 
overview of the safety aspects of transcranial electrical stimulation (tES). However, we noticed that 
while multi-day stimulation studies were discussed, potential changes in adverse effects (AEs) over 
consecutive sessions were not, and the lack of knowledge on the matter was pointed out by the 
authors. We recently completed an experiment in which we investigated this issue. 
This investigation formed part of the larger Optimizing Transcranial Electrical Stimulation for 
Clinical Applications (OptES) Study. The study protocol was approved by the Ethics Committee of 
the North Savo Hospital District, Finland. Written informed consent was obtained from all the 
participants. 
We recruited 82 healthy, right-handed, transcranial direct current stimulation (tDCS) naïve males 
aged 18±40 years. The participants received either active (n=41) or sham (n=41) stimulation in a 
double-blind setting. Each participant took part in five consecutive experimental sessions. Prior to 
the onset of the study, the participants were instructed to abstain from alcohol use for 12 hours and 
consume no more than two doses during the preceding 24 hours, to abstain from caffeine for 3 
hours, and to abstain from smoking and heavy physical exercise for one hour before each session. 
Before the first stimulation session, the participants completed the 10-item version of the &RKHQ¶V
Perceived Stress Scale (PSS) questionnaire (Cohen et al. 1982). Each participant received 20 
minutes of 2 mA stimulation using a neuroConn DC stimulator (neuroConn GmbH, Ilmenau, 
Germany). 
The sham group received 15 seconds of ramping up and ramping down at the beginning, after 
which stimulation was discontinued. The duration of the session was constant, regardless of the 
stimulation type. The electrodes (5×5 cm) were conductive rubber placed inside sponge pads 
soaked with 12 ml of saline. The anode was placed at site F3 and the cathode at site F4 according to 
the international 10±
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both the participant and the experimenter filled in a form in which they were asked to estimate 
possible skin redness (using a mirror), tiredness, mood changes, headache and sensations under the 
electrodes on a scale of 0±100.  
The data contained excess zeros and were non-normally distributed. We compared the variables of 
interest (i.e., skin redness, tiredness, mood changes, headache and sensations under the electrodes) 
between the groups using the Mann-Whitney U-test. For more detailed analysis, a fixed-effects 
zero-inflated Poisson (ZIP) model was used to investigate AE likelihood, and a mixed-effects ZIP 
to investigate AE intensity with age, PSS score and stimulation group used as predictors. The fixed- 
and mixed-effects ZIP consisted of a binary distribution generating structural zeros (which represent 
cases who were not susceptible to the effects) and a Poisson distribution generating the remaining 
cases. Separate models were constructed to investigate the main effects and interaction effects. 
Preliminary analyses were conducted with the SPSS 21 software package, and the Poisson model 
was constructed with the R scripting language (version 3.3.2) package glmmADMB (version 
0.8.3.3). 
In Mann-Whitney U-test analyses, the intensity of skin redness under the electrodes was 
significantly (p<0.05) higher in the active group on all days when reported by the participant, and 
on days 2, 3 and 5 when reported by the experimenter. The active group reported less headache than 
the sham group on days 4 and 5.  
Belonging to the active group predicted a higher likelihood of skin redness in fixed-effects ZIP. 
Higher age predicted a stronger erythema reaction in participant-reported mixed-effects ZIP, while 
in the experimenter-reported model, age, belonging to the active group and higher baseline scores 
for perceived stress were significant predictors. There was a significant interaction, suggesting that 
higher age was a stronger predictor of skin redness in the active group than in the sham group in the 
model utilizing experimenter-reported scores, and borderline significant (p=0.0547) in the model 
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utilizing participant-reported scores. There was a significant interaction between PSS scores and 
belonging to the active group in both models, but in opposite directions. The number of stimulation 
sessions was not a predictor (Table 1). 
In power calculations based on effects sizes (ES; &RKHQ¶VD) drawn from this data, the group sizes 
needed to detect participant-reported AEs were as follows: tiredness: ES = 0.161, n = 604; 
sensations under the electrodes: ES = 0.150, n = 695; mood changes: ES = 0.298, n = 178; 
headache: ES = 0.358, n = 124; and skin redness: ES = 0.705, n = 33. For the experimenter-reported 
AEs, the respective figures were as follows: tiredness: ES = 0.131, n = 922; mood changes: ES = 
0.204, n = 379; and skin redness: ES = 0.659, n = 38. 
While confirming that receiving active tDCS predicted skin redness (Ezquerro et al. 2017; Antal et 
al. 2017), we observed that increased age predicted an increased intensity of redness, particularly in 
the active group. Sensations under the electrodes, tiredness and mood did not differ between the 
groups, perhaps reflecting the successful sham protocol, particularly in the case of the sensations 
induced. However, our power calculations suggest that higher-than-expected numbers of 
participants may be needed to detect most of the above side effects.  
We saw no changes in AEs over the stimulation period of five days, which suggests that repetitive 
sessions do not modify tDCS AEs. However, these observations need to be confirmed with different 
stimulation protocols and populations. In general, both the participants and the experimenter 
reported the same AEs.  
As Antal and co-workers pointed out, while the tDCS AEs are mild and thus manageable, there are 
still several aspects to them that the community of researchers and clinicians are not familiar with, 
including the effect of repeated sessions and factors predicting different AEs. However, there is an 
abundance of existing data that could be used to gain more detailed insights into the predictors of 
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tES AEs. Therefore, investigating such predictors could help in identifying protocols suitable for 
different groups of individuals, and in achieving an ideal risk±benefit ratio for tES treatments. 
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Tables 
Table 1. Fixed- and mixed-effects zero-inflated Poisson models (ZIP) for skin redness under the 
electrodes following transcranial direct current stimulation. The participant-reported fixed-effects 






















































Group -1.914 0.001 -0.897 0.059 
Age 0.028 0.541 -0.017 0.677 
PSS score 0.020 0.668 0.035 0.409 
Interaction 
model 
Group×Age -0.021 0.835 -0.065 0.452 








Group -1.589 0.004 -1.408 0.004 
Age 0.042 0.358 -0.015 0.718 
PSS score 0.024 0.613 0.034 0.422 
Interaction 
model 
Group×Age 0.007 0.952 0.024 0.773 








Group -1.000 0.037 -0.388 0.405 
Age 0.008 0.845 -0.046 0.263 
PSS score 0.013 0.751 0.058 0.165 
Interaction 
model 
Group×Age 0.059 0.482 0.050 0.555 








Group -1.829 <0.001 -2.316 <0.001 
Age 0.040 0.364 -0.018 0.692 
PSS score -0.009 0.842 0.061 0.213 
Interaction 
model 
Group×Age 0.045 0.676 -0.067 0.500 



















Group 0.205 0.107 0.455 <0.001 
Day 0.035 0.346 -0.016 0.587 
Age 0.038 <0.001 0.019 0.008 
PSS score -0.022 0.065 -0.024 0.008 
Interaction 
model 
Group×Day 0.063 0.464 -0.042 0.503 
Group×Age 0.041 0.055 0.047 0.005 
Group×PSS score 0.073 0.029 -0.052 0.004 
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